Hospitals say 340B should not be part of Trump's drug price agenda

Modern Healthcare: Reforming the 340B program should not be undertaken as part of President Donald Trump's effort to lower drug prices, hospital industry representatives are telling HHS.

The suggestion came in comments responding to the Trump administration's Blueprint to Lower Drug Prices released in May. Responses to the document were due July 16.

Read article